Search Results

Press Releases

icometrix is proud to announce the market approval of icobrain aria, the first market-approved solution for monitoring amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease

September 4, 2024

·

7 min read

Genetown

icometrix awarded a grant by The Michael J. Fox Foundation to research brain MRI biomarkers for Parkinson’s disease

icometrix , world leader in imaging artificial intelligence (AI) solutions for people with neurological conditions, has been awarded a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to continue efforts in research towards brain MRI biomarkers for Parkinson’s disease (PD).

June 6, 2023

·

3 min read

icometrix & Queen Mary University of London receive prestigious AI Award from the National Institute for Health and Care Research (NIHR) to investigate the impact of AI applied to MRI in the care of people with multiple sclerosis (MS)

icometrix is proud to announce that, together with Queen Mary University of London, it has been awarded the prestigious AI Award in Health and Care.

March 3, 2023

·

11 min read

BioMidwest

icometrix Announces DocPanel to Introduce icobrain Portfolio

icometrix announced that DocPanel has selected the icobrain portfolio to strengthen its AI imaging capability and transform the market for people with traumatic brain injury.

June 8, 2022

·

3 min read

Genetown

icometrix and Aidoc team up to transform stroke care coordination

icometrix, the world leader in imaging AI solutions for people with neurological conditions, announces a partnership with Aidoc, a leading provider of enterprise AI solutions for medical imaging.

June 22, 2021

·

3 min read

Business

Aidoc and icometrix team up to transform stroke care coordination

Aidoc, leading provider of AI solutions for medical imaging and icometrix, world leader in imaging AI solutions for patients with neurological conditions, announced a partnership that will provide an AI-based Stroke suite for rapid triage of patients with suspected stroke.

June 22, 2021

·

3 min read

Press Releases

FDA authorizes the first AI-driven MRI solution for safer Alzheimer’s treatment

November 14, 2024

·

5 min read

icometrix’s MRI measures for people with Multiple Sclerosis receive Medtech Innovation briefing from the National Institute for Health and Care Evidence (NICE)

ico metrix announced the recent release of a Medtech Innovation Briefing (MIB) [ MIB291 ] from the internationally renowned NICE for the CE markers and FDA cleared ico brain MRI measures in Multiple Sclerosis (MS).

April 21, 2022

·

3 min read

Pharm Country

icometrix selected as one of the 150 most innovative digital health startups worldwide by CB Insights

icometrix recognized for achievements in leading the brain imaging AI space

October 2, 2019

·

2 min read

BioMidwest

icometrix expands icobrain portfolio with AI image analysis solution to help epilepsy patients

icometrix, world leader in software solutions to extract clinically meaningful data from brain scans is proud to announce FDA 510(k) clearance for its icobrain ep solution.

February 10, 2020

·

2 min read